Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 known ✓ | P08173 | 2/20 | 0.35 |
| ▸ | CHRM5 known ✓ | P08912 | 2/20 | 0.35 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.35 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 6/20 | 0.44 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL766983 | 0.97 | KIF11 (0.46) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| Bromide SCHEMBL110208 | 0.94 | KIF11 (0.44) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL10995938 | 0.94 | KIF11 (0.44) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| Iodide SCHEMBL660827 | 0.94 | KIF11 (0.44) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| Water SCHEMBL11171777 | 0.94 | KIF11 (0.44) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| Bicarbonate SCHEMBL11280342 | 0.87 | KIF11 (0.46) | KIF11KCNN4TSHRALDH1A1SMN1; SMN2 | |
| Acetic Acid SCHEMBL5074931 | 0.84 | CYP2C19 (0.45) | KIF11KCNN4ALDH1A1SMN1; SMN2CYP1A2 | |
| Acetic Acid SCHEMBL11284778 | 0.84 | CYP2C19 (0.45) | KIF11KCNN4ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL29152090 | 0.84 | KIF11 (0.38) | KIF11KCNN4TSHRALDH1A1TAAR1 | |
| Hydrochloric Acid SCHEMBL5092615 | 0.79 | KIF11 (0.52) | KIF11KCNN4SMN1; SMN2CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115806569-A | High-temperature-resistant quaternary phosphonium sulfonate organic antibacterial flame-retardant monomer for polyester polymerization, and preparation method and application thereof | 浙江恒逸石化研究院有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-110743621-B | Trivalent copper catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2022-05-24 | — | — | CN | claimed |
| CN-110813380-B | Copper ketone complex catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2022-04-19 | — | — | CN | claimed |
| CN-111151299-B | Copper alkoxide complex catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2020-10-09 | — | — | CN | claimed |
| CN-110743556-B | Copper-based alloy catalyst and preparation method and application thereof | 浙江工业大学 | 2020-08-21 | — | — | CN | claimed |
| CN-107803222-B | Ruthenium complex catalyst for acetylene hydrochlorination | 浙江工业大学 | 2020-06-09 | — | — | CN | claimed |
| CN-111250158-A | Carbon-supported alkaline ionic liquid-metal catalyst and preparation and application thereof | 浙江工业大学 | 2020-06-09 | — | — | CN | claimed |
| CN-111151299-A | Copper alkoxide complex catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2020-05-15 | — | — | CN | claimed |
| CN-108300181-B | Stable powder slurry and preparation method and application thereof | 广东伊诗德新材料科技有限公司 | 2020-03-24 | — | — | CN | claimed |
| CN-110813380-A | Copper ketone complex catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2020-02-21 | — | — | CN | claimed |
| CN-110743621-A | Trivalent copper catalyst, preparation method thereof and application thereof in acetylene hydrochlorination | 浙江工业大学 | 2020-02-04 | — | — | CN | claimed |
| CN-110743624-A | Acetylene hydrochlorination copper-based catalyst and preparation method and application thereof | 浙江工业大学 | 2020-02-04 | — | — | CN | claimed |
| CN-110743556-A | Copper-based alloy catalyst and preparation method and application thereof | 浙江工业大学 | 2020-02-04 | — | — | CN | claimed |
| US-9522915-B2 | Method for preparing an important intermediate of linagliptin | 2Y-CHEM, LTD. (CN) | 2016-12-20 | — | — | US | claimed |
| US-20150274728-A1 | METHOD FOR PREPARING AN IMPORTANT INTERMEDIATE OF LINAGLIPTIN | 2Y-CHEM, LTD. (CN) | 2015-10-01 | — | — | US | claimed |
| US-4831166-A | REACTING ALKYLENE OXIDE WITH ACYLACETATE USING IONIC HALIDE CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1989-05-16 | — | — | US | claimed |
| EP-4314107-B1 | STORAGE STABLE THERMOSETTING POWDER COATING COMPOSITIONS COMPRISING AN EPOXY CROSSLINKER AND A POLYESTER RESIN PREPARED FROM CITRIC ACID AND/OR CITRIC ACID ANHYDRIDE, AND POWDER COATINGS THEREOF HAVING AT LEAST GOOD CHEMICAL RESISTANCE AND AT LEAST VERY GOOD ADHESION | COVESTRO NETHERLANDS BV (NL) | 2024-12-25 | — | — | EP | disclosed |
| EP-4467588-A1 | MODIFIED EPOXY RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | Mitsubishi Chemical Corporation (JP) | 2024-11-27 | — | — | EP | disclosed |
| US-4066629-A | PROCESS FOR PREPARING CARBODIIMIDES UTILIZING A PHOSPHONIUM SALT CATALYST | CELANESE CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3992370-A | 1,1-Dichloro-1a,1b-dihydrodibenzo(b,f)cycloprop(d)azepine-6(1H)-carboxaldehyde | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274728-A1 | METHOD FOR PREPARING AN IMPORTANT INTERMEDIATE OF LINAGLIPTIN | DPP4, DPP9, DPP3 | CHRM4 3422/4885CHRM5 4660/4885CHRM3 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.